A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men

NCT06006598 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1584862
DRUG: Placebo matching BI 1584862
DRUG: midazolam

Sponsor

Boehringer Ingelheim